Table 1.
Characteristics | Clinic BP–Mean Awake ABP, mm Hg | ||||
---|---|---|---|---|---|
White‐Coat Effect | Reference | Masked Effect | |||
≥10 | 5 to <10 | 0 to <5 | −5 to <0 | ≥−5 | |
(N=93) | (N=56) | (N=70) | (N=97) | (N=294) | |
Age, y | 60.4±9.3 | 61.2±8.4 | 59.5±10.9 | 58.5±9.7 | 60.1±10.6 |
Female sex | 43 (46.2) | 33 (58.9) | 29 (41.4) | 36 (37.1) | 92 (31.3) |
Heart disease | 35 (35) | 34 (61) | 56 (58) | 65 (70) | 197 (67) |
eGFR, mL/min per 1.73 m2 | 39.9±16.5 | 36.3±15.0 | 35.9±15.2 | 42.7±16.3 | 39.2±15.2 |
Proteinuria, median (IQR), g/ga | 0.05 (0.02–0.1) | 0.09 (0.04–0.34) | 0.07 (0.03–0.26) | 0.05 (0.03–0.29) | 0.06 (0.03–0.32) |
Randomized to strict BP control during the AASK Cohort Study | 49 (52.7) | 30 (53.6) | 30 (42.9) | 48 (49.5) | 147 (50.0) |
Data are given as mean±SD or number (percentage), unless otherwise indicated. AASK indicates African American Study of Kidney Disease and Hypertension; ABP, ambulatory BP; BP, blood pressure; eGFR, estimated glomerular filtration rate; IQR, interquartile range; SBP, systolic BP.
Missing in N=81.